1. Home
  2. APRE vs GLE Comparison

APRE vs GLE Comparison

Compare APRE & GLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • GLE
  • Stock Information
  • Founded
  • APRE 2006
  • GLE 2018
  • Country
  • APRE United States
  • GLE Hong Kong
  • Employees
  • APRE N/A
  • GLE N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • GLE
  • Sector
  • APRE Health Care
  • GLE
  • Exchange
  • APRE Nasdaq
  • GLE NYSE
  • Market Cap
  • APRE 21.2M
  • GLE 24.0M
  • IPO Year
  • APRE 2019
  • GLE 2024
  • Fundamental
  • Price
  • APRE $2.62
  • GLE $1.32
  • Analyst Decision
  • APRE Strong Buy
  • GLE
  • Analyst Count
  • APRE 2
  • GLE 0
  • Target Price
  • APRE $15.50
  • GLE N/A
  • AVG Volume (30 Days)
  • APRE 35.9K
  • GLE 77.3K
  • Earning Date
  • APRE 03-25-2025
  • GLE 11-01-2024
  • Dividend Yield
  • APRE N/A
  • GLE N/A
  • EPS Growth
  • APRE N/A
  • GLE N/A
  • EPS
  • APRE N/A
  • GLE 0.02
  • Revenue
  • APRE $1,310,839.00
  • GLE $6,333,093.00
  • Revenue This Year
  • APRE $134.21
  • GLE N/A
  • Revenue Next Year
  • APRE N/A
  • GLE N/A
  • P/E Ratio
  • APRE N/A
  • GLE $63.54
  • Revenue Growth
  • APRE 130.31
  • GLE 10.67
  • 52 Week Low
  • APRE $2.15
  • GLE $1.20
  • 52 Week High
  • APRE $8.85
  • GLE $5.44
  • Technical
  • Relative Strength Index (RSI)
  • APRE 30.05
  • GLE N/A
  • Support Level
  • APRE $2.59
  • GLE N/A
  • Resistance Level
  • APRE $3.72
  • GLE N/A
  • Average True Range (ATR)
  • APRE 0.35
  • GLE 0.00
  • MACD
  • APRE -0.13
  • GLE 0.00
  • Stochastic Oscillator
  • APRE 1.41
  • GLE 0.00

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About GLE GLOBAL ENGINE GROUP HOLDING LIMITED

Global Engine Group Holding Ltd offers integrated solutions by using ICT solutions to drive business outcomes and innovation. Its service offerings comprise services to telecom operators, including the one-stop shop purchase from telecom license application service to turnkey network setup as well as service outsourcing; business planning, development, technical and operations consulting programs structured to target the cloud computing and data center providers; system design, planning, development and operation services to technology companies; cloud platform deployment, IT system design and configuration services, maintenance services, data center colocation service and cloud service.

Share on Social Networks: